Pearson, syndrome
|
Incidence < 1.106. Mitochondrial cytopathy due to the deletion of part of the mitochondrial DNA.
Clinically, the disease can present as
- a refractory sideroblastic anemia in infants (onset at the median age of 5 months), associated with neutropenia and thrombocytopenia of varying intensity; it usually resolves spontaneously between 1 and 3 years of age (66 %)
- an exocrine pancreatic dysfunction (27-62 %): delayed growth, vomiting, diarrhea
- high blood levels of lactic acid and episodes of lactic acidosis; the lactate/pyruvate ratio is > 20
with gradual appearance of
- hepatomegaly (30-70 %)
- hypotonia of varying severity
- a renal tubulopathy, which can lead to progressive kidney failure
- ocular involvement: ptosis, retinitis pigmentosa, cataracts
- various endocrine abnormalities: insulin-dependent diabetes, hypothyroidism, adrenal insufficiency
Death occurs before 3 years of age in 50 % of cases: infection, metabolic crisis, heart rhythm disorders.
Children who survive infancy often develop the Kearns-Sayre syndrome (see this term). Increased risk of malignant myelodysplastic syndrome.
Anesthetic implications:
total blood count, basal lactic acid levels, ECG and echocardiography. Anesthetic management of a mitochondrial cytopathy (see this term).
References:
- Yoshimi A, Ishikawa K, Niemeyer C, Grünert SC.
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure.
Orphanet Journal of Rare Diseases 2022 ; 17:379
Updated: January 2023